Kits Eyecare Ltd.
KITS.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.79% | 31.08% | 29.80% | 30.10% | 25.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.79% | 31.08% | 29.80% | 30.10% | 25.85% |
| Cost of Revenue | 23.41% | 26.86% | 27.42% | 30.50% | 26.62% |
| Gross Profit | 39.65% | 39.48% | 34.51% | 29.32% | 24.33% |
| SG&A Expenses | 26.81% | 26.96% | 22.76% | 22.06% | 19.12% |
| Depreciation & Amortization | -39.98% | -51.82% | -58.38% | -45.76% | -34.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.86% | 25.86% | 24.54% | 26.39% | 23.01% |
| Operating Income | 1,287.80% | 1,998.76% | 661.18% | 286.08% | 125.66% |
| Income Before Tax | 25,669.47% | 1,563.35% | 522.86% | 249.32% | 100.81% |
| Income Tax Expenses | 1,701.27% | 2,089.31% | 606.38% | 292.08% | 121.55% |
| Earnings from Continuing Operations | 5,073.72% | 1,370.47% | 494.65% | 236.31% | 96.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5,073.72% | 1,370.47% | 494.65% | 236.31% | 96.52% |
| EBIT | 1,287.80% | 1,998.76% | 661.18% | 286.08% | 125.66% |
| EBITDA | 254.53% | 320.50% | 371.70% | 287.78% | 769.37% |
| EPS Basic | 4,907.69% | 1,378.95% | 490.64% | 235.44% | 96.30% |
| Normalized Basic EPS | 28,500.00% | 1,551.02% | 519.28% | 248.36% | 100.75% |
| EPS Diluted | 2,060.66% | 5,360.00% | 377.81% | 207.38% | 92.34% |
| Normalized Diluted EPS | 35,700.00% | 1,830.77% | 482.10% | 236.66% | 99.44% |
| Average Basic Shares Outstanding | 1.34% | 1.02% | 0.65% | 0.39% | -2.23% |
| Average Diluted Shares Outstanding | 1.07% | 1.34% | 4.37% | 5.92% | 1.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |